ESC 365 - What happens >10 years after percutaneous septal ablation for hypertrophic obstructive cardiomyopathy? Ultra long-term follow-up of 120 patients.

ESC Premium Access

What happens >10 years after percutaneous septal ablation for hypertrophic obstructive cardiomyopathy? Ultra long-term follow-up of 120 patients.

Session: Advances in Pathophysiology and Treatment of Hypertrophic Cardiomyopathy

Topic: Hypertrophic Cardiomyopathy

Speaker: Professor L. Faber (Bünde, DE)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Professor Lothar Faber

Lukas-Hospital, Bünde (Germany)

0 follower

3 more presentations in this session

Lifetime mortality associated with hypertrophic cardiomyopathy: 28-year outcome of an historical cohort

Speaker: Mr N. Maurizi (Lausanne, CH)

Is alcohol septal ablation in women performed too late?

Speaker: Doctor A. Batzner (Wurzburg, DE)

High sensitivity troponin I in hypertrophic cardiomyopathy

Speaker: Doctor J. Osmanska (Glasgow, GB)

Access the full session

Advances in Pathophysiology and Treatment of Hypertrophic Cardiomyopathy

Speakers: Professor L. Faber, Mr N. Maurizi, Doctor A. Batzner, Doctor J. Osmanska

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources